| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |